Baxter International Inc. (0QK8)
LSE
Closed
Aug 26, 2026
Day's Range
26.0052 wk Range
15.74Overview - 0QK8 - Baxter International Inc.
Key Statistics
Valuation
Enterprise Value
21.08B
P/E (Trailing)
‪0.12‬
Price / Book
‪2.19‬
EV / EBITDA
‪11.19‬
Profitability
Profit Margin
‪-9.26%‬
Operating Margin
‪14.42%‬
Return on Assets
‪2.84%‬
Return on Equity
‪-14.37%‬
Ownership
Float
514.51M
Held by Insiders
‪0.34%‬
Held by Institutions
‪110.19%‬
Price stats
Beta
‪0.59‬
50-Day Avg
‪40.39‬
200-Day Avg
‪39.85‬
Dividends
Frequency
Quarterly
Peers - 0QK8 - Baxter International Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on LSE.
- 0QK8LSEBaxter International Inc.+8.63%52-week change0.13P/E (Trailing)‪-9.26%‬Profit Margin
- ATRLSESchroder Asian Total Return Investment Company plc+29.59%52-week change10.07P/E (Trailing)—Profit Margin
- AMSLSEAdvanced Medical Solutions Group plc+27.05%52-week change56.22P/E (Trailing)‪4.34%‬Profit Margin
- AVGLSEAvingtrans Plc+38.64%52-week change34.29P/E (Trailing)‪4.54%‬Profit Margin
- EYELSEEagle Eye Solutions Group Plc+55.67%52-week change65.00P/E (Trailing)‪-0.20%‬Profit Margin
- SPECLSEInspecs Group PLC+52.17%52-week change-978.72P/E (Trailing)‪-4.98%‬Profit Margin
- 0ADYLSEWest Pharmaceutical Services, Inc.+30.65%52-week change—P/E (Trailing)‪16.98%‬Profit Margin
Profile Summary - 0QK8 - Baxter International Inc.
About
Baxter International Inc. is a multinational healthcare company headquartered in Deerfield, Illinois, founded in 1931. It provides a broad portfolio of essential medical products and therapies focused on treating chronic and acute conditions in hospital and renal care settings. The company operates through key…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
